Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schattenberg

Showing results (241-250 of 333) with videos related to

Pageof 34
Sort By:
Biomedicines|December 24, 2021
Systematic Review with Meta-Analysis: Diagnostic Accuracy of Pro-C3 for Hepatic Fibrosis in Patients with Non-Alcoholic Fatty Liver DiseaseAnne Linde Mak, Jenny Lee, Anne-Marieke van Dijk, et al.
The American Journal of Gastroenterology|November 30, 2020
A Sequential Algorithm Combining ADAPT and Liver Stiffness Can Stage Metabolic-Associated Fatty Liver Disease in Hospital-Based and Primary Care PatientsMohammed Eslam, Grace Lai-Hung Wong, Ahmed M Hashem, et al.
The American Journal of Gastroenterology|October 12, 2016
Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD FibrosisStuart McPherson, Tim Hardy, Jean-Francois Dufour, et al.
Oncotarget|February 1, 2018
Loss of organic cation transporter 3 (Oct3) leads to enhanced proliferation and hepatocarcinogenesisJohanna Vollmar, Anja Lautem, Ellen Closs, et al.
Clinical Kidney Journal|March 27, 2026
Increased albuminuria is highly prevalent in the general population: prevalence of CKD in the Gutenberg Health StudyDaniel Kraus, Alexander Gieswinkel, Simone Cosima Boedecker-Lips, et al.
Journal of Hepatology|January 23, 2021
A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCAJörn M Schattenberg, Albert Pares, Kris V Kowdley, et al.
BMC Gastroenterology|February 12, 2017
Efficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infectionStefan Bourgeois, Hans Van Vlierberghe, Christophe Moreno, et al.
Journal of Clinical Medicine|May 28, 2022
Influence of Advanced Organ Support (ADVOS) on Cytokine Levels in Patients with Acute-on-Chronic Liver Failure (ACLF)Leonard Kaps, Eva Maria Schleicher, Carolina Medina Montano, et al.
Medicina (Kaunas, Lithuania)|December 31, 2025
Psychosocial Work Stress, Resilience and the Risk of Tinnitus-Results from a Population-Based Cohort StudyBerit Hackenberg, Julia Döge, Karoline O'Brien, et al.
Plos One|October 11, 2024
Assessment of psychological resilience in a large cohort of the general population: Validation and norm values of the RS-5Anna C Reinwarth, Omar Hahad, Jasmin Ghaemi Kerahrodi, et al.
Pageof 34

Showing results (241-250 of 333) with videos related to

Sort By:
Pageof 34
Biomedicines|December 24, 2021
Systematic Review with Meta-Analysis: Diagnostic Accuracy of Pro-C3 for Hepatic Fibrosis in Patients with Non-Alcoholic Fatty Liver DiseaseAnne Linde Mak, Jenny Lee, Anne-Marieke van Dijk, et al.
The American Journal of Gastroenterology|November 30, 2020
A Sequential Algorithm Combining ADAPT and Liver Stiffness Can Stage Metabolic-Associated Fatty Liver Disease in Hospital-Based and Primary Care PatientsMohammed Eslam, Grace Lai-Hung Wong, Ahmed M Hashem, et al.
The American Journal of Gastroenterology|October 12, 2016
Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD FibrosisStuart McPherson, Tim Hardy, Jean-Francois Dufour, et al.
Oncotarget|February 1, 2018
Loss of organic cation transporter 3 (Oct3) leads to enhanced proliferation and hepatocarcinogenesisJohanna Vollmar, Anja Lautem, Ellen Closs, et al.
Clinical Kidney Journal|March 27, 2026
Increased albuminuria is highly prevalent in the general population: prevalence of CKD in the Gutenberg Health StudyDaniel Kraus, Alexander Gieswinkel, Simone Cosima Boedecker-Lips, et al.
Journal of Hepatology|January 23, 2021
A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCAJörn M Schattenberg, Albert Pares, Kris V Kowdley, et al.
BMC Gastroenterology|February 12, 2017
Efficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infectionStefan Bourgeois, Hans Van Vlierberghe, Christophe Moreno, et al.
Journal of Clinical Medicine|May 28, 2022
Influence of Advanced Organ Support (ADVOS) on Cytokine Levels in Patients with Acute-on-Chronic Liver Failure (ACLF)Leonard Kaps, Eva Maria Schleicher, Carolina Medina Montano, et al.
Medicina (Kaunas, Lithuania)|December 31, 2025
Psychosocial Work Stress, Resilience and the Risk of Tinnitus-Results from a Population-Based Cohort StudyBerit Hackenberg, Julia Döge, Karoline O'Brien, et al.
Plos One|October 11, 2024
Assessment of psychological resilience in a large cohort of the general population: Validation and norm values of the RS-5Anna C Reinwarth, Omar Hahad, Jasmin Ghaemi Kerahrodi, et al.
Pageof 34